Insider Cluster (2 insiders) ·Filed Apr 24, 2026
Insider cluster: 2 insiders, $22K total
Actionable Insight • Neutral
No actionable signal — the cluster is too small to indicate any material change. Monitor for any future 8-K filings (e.g., clinical trial results) that could affect the stock, and watch for larger insider activity exceeding 0.1% of market cap.
Final — all horizons settled through T+60d
CGEN ▼ -19.68% at T+60d
NEUTRAL call ✗ call lost -19.68% · α vs SPY -24.76% · entry $3.10 → $2.49
T+1d
-5.81%
call -5.81% · α -5.97%
$2.92
settled 5mo ago
T+5d
-14.19%
call -14.19% · α -15.10%
$2.66
settled 5mo ago
T+20d
-15.81%
call -15.81% · α -19.83%
$2.61
settled 4mo ago
T+60d
-19.68%
call -19.68% · α -24.76%
$2.49
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Two insiders at Compugen (CGEN) sold shares totaling ~$22K after exercising stock options. The dollar amount represents less than 0.01% of market cap, making this a routine and immaterial cluster.
Key Financial Metrics
Direction
selling
Total Value
$22.4K
Insiders
2
Key Facts
- CEO Ophir Eran sold 5,000 shares at $3.20 for $16,001 after exercising 5,000 options at $0.83 per share.
- SVP Zurit Levine sold 2,000 shares at $3.20 for $6,400 after exercising 4,000 options (2,000 at $0 and 2,000 at $1.15).
- Total open-market sales: $22,401, which is 0.0076% of Compugen's $293M market cap.
- All trades occurred on the same day (April 24, 2026) and appear to be tax-related or cash-out after option exercises.
Financial Impact
$22,401 in total insider sales (negligible relative to $293M market cap)
Risk Factors
- Routine insider sales, no material risk identified.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CGEN-1777320222214 |
8 reports for CGEN
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 8w ago | 6-K | $2.38 $2.56 | ▲ +7.56% | ▲ +6.33% | $2.31 (−2.94%) |
Aug 3, 2026 8w ago | 6-K | $2.38 $2.56 | ▲ +7.56% | ▲ +6.33% | $2.31 (−2.94%) |
Jun 9, 2026 16w ago | EFFECT | $2.02 $2.39 | ▲ +18.32% | ▲ +16.87% | $2.31 (+14.36%) |
May 18, 2026 19w ago | 6-K | $2.86 $2.03 | ▼ −29.02% | ▼ −30.60% | $2.31 (−19.23%) |
Apr 24, 2026 23w ago | Insider Cluster | $3.10 $2.61 | ▼ −15.81% | ▼ −19.83% | $2.31 (−25.48%) |
Apr 14, 2026 24w ago | Insider Cluster | $2.88 $2.87 | ▼ −0.35% | ▼ −6.64% | $2.31 (−19.79%) |
Apr 13, 2026 24w ago | 144 | $2.76 $2.87 | ▲ +3.99% | ▼ −3.74% | $2.31 (−16.30%) |
Mar 26, 2026 27w ago | Insider Cluster | $2.06 $3.10 | ▲ +50.49% | ▲ +39.82% | $2.31 (+12.14%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Mon (64h 16m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access